Brief: Rosetta Genomics' patent on therapeutic use of mir-34a upheld by European patent office in opposition proceedings
29/04/2015 13:56
April 29 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Genomics' patent on therapeutic use of mir-34a upheld by European patent office in opposition proceedings * Says epo upheld validity European patent no. 2126078, following proceedings against co's patent held on April 23 in Munich, Germany * Source text for Eikon ID:nBwPdp8za * Further company coverage ROSG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics